143 related articles for article (PubMed ID: 4521049)
1. Antibody-mediated suppression of lymphoma: participation of platelets, lymphocytes, and nonphagocytic macrophages.
Shin HS; Hayden ML; Gately CL
Proc Natl Acad Sci U S A; 1974 Jan; 71(1):163-6. PubMed ID: 4521049
[TBL] [Abstract][Full Text] [Related]
2. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated suppression of grafted lymphoma cells. II. Participation of macrophages.
Shin HS; Kaliss N; Borenstein D; Gately MK
J Exp Med; 1972 Aug; 136(2):375-80. PubMed ID: 5043417
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated suppression of grafted lymphoma. IV. Influence of time of tumor residency in vivo and tumor size upon the effectiveness of suppression by syngeneic antibody.
Shin HS; Economou JS; Pasternack GR; Johnson RJ; Hayden ML
J Exp Med; 1976 Nov; 144(5):1274-83. PubMed ID: 993726
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated suppression of tumor growth. II. Macrophage and platelet cooperation with murine IgG1 isolated from alloantiserum.
Johnson RJ; Pasternack GR; Shin HS
J Immunol; 1977 Feb; 118(2):494-7. PubMed ID: 839067
[TBL] [Abstract][Full Text] [Related]
6. In vitro reactivity of macrophages and lymphocytes from ultraviolet-irradiated mice.
Norbury KC; Kripke ML; Budmen MB
J Natl Cancer Inst; 1977 Oct; 59(4):1231-5. PubMed ID: 903998
[TBL] [Abstract][Full Text] [Related]
7. Eradication of lymphoma cells with allogeneic immune peritoneal cells.
Dullens HF; den Otter W
Experientia; 1973 Apr; 29(4):479-81. PubMed ID: 4708353
[No Abstract] [Full Text] [Related]
8. Specific T cell-dependent, antigen-antibody mediated suppression of macrophages: abrogation by nonspecifically stimulated T cells.
Rao VS; Mokyr MB; Gershon RK; Mitchell MS
J Immunol; 1977 Jun; 118(6):2117-24. PubMed ID: 325141
[No Abstract] [Full Text] [Related]
9. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
Evans R; Alexander P
Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
[TBL] [Abstract][Full Text] [Related]
10. Specific tumor-induced suppression of lymphocyte activity in the antibody-dependent tumoricidal reaction.
Stolfi RL; Stolfi LM; Fugmann RA; Martin DS
Int J Cancer; 1974 Nov; 14(5):625-32. PubMed ID: 4142474
[No Abstract] [Full Text] [Related]
11. Resistance to transplantation of spontaneous AKR lymphoma cells by substrains of AKR mice. In vivo resistance and generation of an H-2 restricted CML response.
Zatz MM
Cell Immunol; 1978 Mar; 36(2):251-62. PubMed ID: 305294
[No Abstract] [Full Text] [Related]
12. The interplay of lymphoid cells and macrophages in tumour immunity.
Alexander P; Evans R; Grant CK
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):645-58. PubMed ID: 5050874
[No Abstract] [Full Text] [Related]
13. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
Gjedde SB
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
[TBL] [Abstract][Full Text] [Related]
14. Co-operation between macrophages and a factor from lymphocytes in tumor lysis in vitro.
Yamazaki M; Shinoda H; Mizuno D
Gan; 1975 Oct; 66(5):489-97. PubMed ID: 1082827
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the immune response to transplantation antigens. V. A comparison of the effects of antilymphocytic serum and enhancing alloantiserum on effector mechanisms of allograft rejection.
Zola H
Clin Exp Immunol; 1975 Feb; 19(2):367-76. PubMed ID: 1212805
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
Gabizon A; Leibovich SJ; Goldman R
J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
[TBL] [Abstract][Full Text] [Related]
17. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
Gordon WC; Prager MD
Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
Plata F; Gomard E; Leclerc JC; Levy JP
J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
[No Abstract] [Full Text] [Related]
19. Tumor cell cytostasis by macrophages and antibody in vitro. I. Resolution into contact-dependent and contact-independent steps.
Pasternack GR; Johnson RJ; Shin HS
J Immunol; 1978 May; 120(5):1560-6. PubMed ID: 307017
[TBL] [Abstract][Full Text] [Related]
20. Active immunoprophylaxis and immunotherapy in two mouse lymphoma models.
Ghose T; Guclu A; Tai J; Norvell ST; MacDonald AS
J Natl Cancer Inst; 1976 Aug; 57(2):303-15. PubMed ID: 794497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
